SIGN IN / REGISTER
(1) -
$
125.57
Menu
Home
Products
Providers
Education
Forms
Contact Us
Toggle Dropdown
by Item #
by Manufacturer #
by Brand
Home
/
Vaccines / Refrig Pharma
/ Antimuscarinic / Antispasmodic Ipratropium Bromide 0.02%, 0.2 mg / mL Unit Dose, Inhalation Solution Vial 25 Vials
“Nitrostat® Nitrate Nitroglycerin 0.4 mg Sublingual Tablet Bottle 25 Tablets” has been added to your cart.
View cart
Antimuscarinic / Antispasmodic Ipratropium Bromide 0.02%, 0.2 mg / mL Unit Dose, Inhalation Solution Vial 25 Vials
UOM CARTON/25
$
5.77
10000 in stock
Antimuscarinic / Antispasmodic Ipratropium Bromide 0.02%, 0.2 mg / mL Unit Dose, Inhalation Solution Vial 25 Vials quantity
Add to cart
Category:
Vaccines / Refrig Pharma
Description
Description
Item ID #
12548900
Manufacturer #
1254804
Brand
Related products
#73038900 Mfr#
Depo-Medrol® Corticosteroid Methylprednisolone Acetate 40 mg / mL Injection Single Dose Vial 1 mL
Features
Sterile Aqueous Suspension
DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intraarticular, soft tissue or intralesional injection
Not for intravenous use
UOM EACH/1
$318.588
Add to cart
#93858910 Mfr# H93850
Top Fill Bag 1500 mL, PVC
Features
Source container for pump tube sets
With reclosable wide-mouth opening
This product is required to be reported under California Proposition 65
UOM CASE/25
$470.148
Add to cart
#40988900 Mfr# 1107424
Nitrostat® Nitrate Nitroglycerin 0.4 mg Sublingual Tablet Bottle 25 Tablets
Features
NITROSTAT is a stabilized sublingual compressed nitroglycerin tablet
The principal pharmacological action of nitroglycerin is relaxation of vascular smooth muscle
Although venous effects predominate, nitroglycerin produces, in a dose-related manner, dilation of both arterial and venous beds
UOM CARTON/4
$121.908
Add to cart
#58908900 Mfr# 589-05
Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
UOM CASE/5
$869.472
Add to cart